An interventional study of Protocolized post-extubation respiratory support and Usual Care in Mechanical Ventilation Complication, Acute Respiratory Failure and Intubation Complication, sponsored by Vanderbilt University Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-29.
Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment
Invasive mechanical ventilation is common in the medical intensive care unit, and the period of time following extubation remains high risk as 11 to 15% of patients require reintubation after their first extubation. Reintubation is associated with increased rates of nosocomial infection and is an independent predictor of mortality. Non-invasive ventilation and high flow nasal cannula are the only therapies that have been shown to reduce the rate of reintubation. Recent clinical trials suggest that all patients might benefit from some form of post-extubation respiratory support, but use of these therapies in usual care remains low. PROPER is a cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol to provide post-extubation respiratory support to all patients, compared to usual care. The trial will enroll patients undergoing extubation in the Medical ICU at Vanderbilt from October 2017 until March 2019. The primary outcome will be reintubation within 96 hours.
PROPER is a prospective, pragmatic, cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol for post-extubation respiratory support to usual care. The primary outcome will be reintubation by 96 hours. All adults (age 18 or older) who receive at least 12 hours of mechanical ventilation and are extubated in the Vanderbilt Medical ICU will be enrolled in the trial. The ICU will be divided into 2 clusters, based on the geographic areas covered by the two respiratory therapist dedicated to that ICU. The study will occur in three month blocks. One cluster will be randomized to receive protocolized post-extubation respiratory support (as prescribed by a protocol and delivered by a respiratory therapist), while the other cluster receives usual care, which can include post-extubation respiratory support when requested by the clinical team. At the end of three months, the clusters will cross-over, such that each cluster will spend half of the study receiving protocolized post-extubation respiratory and half of the study receiving usual care. It is anticipated that approximately 630 patients will be enrolled from the medical ICU during the 18 month study period.
Exclusion Criteria:
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Other: Protocolized post-extubation respiratory support
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Other: Usual Care
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Reintubation
Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation
Time frame: within 96 hours of extubation
All-cause In-hospital Death
All cause mortality, censored at the first of hospital discharge or 28 days after extubation
Time frame: from extubation to discharge or 28 days post-extubation
ICU-free Days
number of days alive from final ICU transfer until study day 28
Time frame: from extubation to discharge or 28 days post-extubation
Ventilator-free Days
number of days alive from final invasive mechanical ventilation until study day 28
Time frame: from extubation to discharge or 28 days post-extubation
Time to Reintubation
Time from extubation to reintubation
Time frame: from extubation to discharge or 28 days post-extubation
Number of Patients Requiring Re-intubation for Respiratory Indication
Number of patients in each group with respiratory indication for reintubation.
Time frame: within 96 hours of extubation
Number of Patients Requiring Reintubation for Laryngeal Edema
Percentage of patients in each group with laryngeal edema as the indication for reintubation
Time frame: within 96 hours of extubation
Number of Patients With Delirium
As defined by Confusion Assessment Method for the ICU (CAM-ICU) score and reported by bedside nurse. A report of "Yes" indicates the presence of delirium, which is reflected in the reported cases.
Time frame: within 96 hours of extubation
Number of Patients With Agitation
As defined by RAS score and reported by bedside nurse
Time frame: within 96 hours of extubation
Lowest S/F Ratio
Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
Time frame: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
Highest Respiratory Rate
Highest respiratory rate
Time frame: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation
Use of High Flow Nasal Cannula (HFNC) or Non-invasive Ventilation (NIV) Beyond 24 Hours Post-extubation
Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation
Time frame: from 24 hours post extubation to 96 hours post-extubation
| Milestone | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Started | 359 | 392 |
| Completed | 359 | 392 |
| Not completed | 0 | 0 |
Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Reintubation | 57 | 52 |
All cause mortality, censored at the first of hospital discharge or 28 days after extubation
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| All-cause In-hospital Death | 29 | 41 |
number of days alive from final ICU transfer until study day 28
| days | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| ICU-free Days | 26 (23 to 26) | 26 (22 to 26) |
number of days alive from final invasive mechanical ventilation until study day 28
| days | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Ventilator-free Days | 28 (28 to 28) | 28 (28 to 28) |
Time from extubation to reintubation
| hours | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Time to Reintubation | 56 (21 to 147) | 47 (18 to 163) |
Number of patients in each group with respiratory indication for reintubation.
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Number of Patients Requiring Re-intubation for Respiratory Indication | 35 | 33 |
Percentage of patients in each group with laryngeal edema as the indication for reintubation
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Number of Patients Requiring Reintubation for Laryngeal Edema | 0 | 2 |
As defined by Confusion Assessment Method for the ICU (CAM-ICU) score and reported by bedside nurse. A report of "Yes" indicates the presence of delirium, which is reflected in the reported cases.
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Number of Patients With Delirium | 160 | 151 |
As defined by RAS score and reported by bedside nurse
No measurements were reported for this outcome.
Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
| ratio of O2 saturation to concentration | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| 0-6 hours | 237.5 (205.0 to 254.3) | 268.5 (224.4 to 344.4) |
| 6-12 hours | 242.5 (222.5 to 303.3) | 318.5 (240.0 to 438.1) |
| 12-24 hours | 242.5 (214.6 to 340.7) | 327.6 (240.0 to 438.1) |
Highest respiratory rate
| breaths per minute | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| 0-6 hours | 23 (20 to 28) | 24 (21 to 28) |
| 6-12 hours | 24 (19 to 28) | 24 (20 to 29) |
| 12-24 hours | 25 (21 to 30) | 25 (21 to 29) |
Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation
| Participants | Protocolized Post-extubation Respiratory Support | Usual Care |
|---|---|---|
| Use of High Flow Nasal Cannula (HFNC) or Non-invasive Ventilation (NIV) Beyond 24 Hours Post-extubation | 26 | 14 |
Collected over Adverse events were collected from enrollment to 28 days after enrollment. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Protocolized Post-extubation Respiratory Support | 29/359 (8.1%) | 0/359 (0%) | 0/359 (0%) |
| Usual Care | 41/392 (10.5%) | 0/392 (0%) | 0/392 (0%) |
| Age, Continuous(years) | Protocolized Post-extubation Respiratory Support | Usual Care | Total |
|---|---|---|---|
| Median | 56 (43 to 66) | 57 (42 to 66) | 57 (42 to 66) |
| Sex: Female, Male(Participants) | Protocolized Post-extubation Respiratory Support | Usual Care | Total |
|---|---|---|---|
| Female | 155 | 187 | 342 |
| Male | 204 | 205 | 409 |
| Race/Ethnicity, Customized(Participants) | Protocolized Post-extubation Respiratory Support | Usual Care | Total |
|---|---|---|---|
| White | 287 | 317 | 604 |
| Black or African American | 58 | 59 | 117 |
| Asian | 3 | 8 | 11 |
| Other | 5 | 4 | 9 |
| Not Reported | 6 | 4 | 10 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes
Supporting information: Study protocol, Sap
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vanderbilt University Medical Center